Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 20

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Proteomic Analysis of the Retina: Identification of Key Players in Photoreceptor Outer Segment Assembly

M.M. Jablonski; G. McCollum; J.S. Penn; X.F. Wang

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1089. doi:

ARVO Annual Meeting Abstract May 2006

Anecortave Acetate Inhibits the Hypoxic Induction of VEGF Splice Variants

R. Landers; R. Yang; G.W. McCollum; D.P. Bingaman; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1755. doi:

ARVO Annual Meeting Abstract May 2006

Bioactivity And Characterization Of Antiangiogenic Vitreous Proteins After Penetrating Ocular Injury

W.Y. Boadi; G.W. McCollum; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1761. doi:

ARVO Annual Meeting Abstract May 2006

In vitro and in vivo Studies of cPLA2 Involvement in VEGF Mediated Retinal Neovascularization

J.M. Barnett; J.A. Fowler; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2600. doi:

ARVO Annual Meeting Abstract May 2006

Peroxisome Proliferators Activated Receptor and Cycloxygenase Expression in Human Retinal Microvascular Endothelial Cells

Q. Song; C.A. Odonkor; G.W. McCollum; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5339. doi:

ARVO Annual Meeting Abstract May 2005

Antiangiogenic Vitreous Proteins After Penetrating Ocular Injury

W.Y. Boadi; M.L. Clark; K.J. Helmcke; G.W. McCollum; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):463. doi:

ARVO Annual Meeting Abstract May 2005

Src Family Kinases, New Therapeutic Targets for Intervention of VEGF–Mediated Retinopathy

X.Q. Werdich; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1426. doi:

ARVO Annual Meeting Abstract May 2005

Prostaglandin E2 Synthase mRNA Levels Are Increased in Response to Hypoxia in Rat Muller Cells

G.W. McCollum; R. Yang; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):2974. doi:

ARVO Annual Meeting Abstract May 2005

Matrix Metalloproteinase–2 and –9 Knockout Mice Are Resistant to Oxygen–induced Retinopathy

J.A. Fowler; J.M. Barnett; X.Q. Werdich; R. Yang; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3257. doi:

ARVO Annual Meeting Abstract May 2005

The Receptor Tyrosine Kinase Inhibitor, AL–39324, Completely Inhibits Preretinal NV in the Rat OIR Model

X. Gu; R.A. Landers; J.S. Penn; K.P. Thomas; S. Stacy; D.P. Bingaman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3262. doi:

ARVO Annual Meeting Abstract May 2005

Expression of Protein Kinase CK2 in the Retina and Retinal Neovascularization

A.A. Kramerov; M. Saghizadeh; S. Caballero; M. Montenarh; L.A. Pinna; J.S. Penn; M.B. Grant; A.V. Ljubimov

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4753. doi:

ARVO Annual Meeting Abstract May 2005

The Effect of Anecortave Acetate on VEGF Message and Protein Levels in Hypoxic Müller Cells and in Rat OIR

R. Yang; G.W. McCollum; D.P. Bingaman; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4177. doi:

ARVO Annual Meeting Abstract May 2005

Hypoxia–Induced COX–2 Translocation: In vivo and in vitro Studies

J.M. Barnett; J.A. Fowler; G.W. McCollum; R. Yang; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4188. doi:

ARVO Annual Meeting Abstract May 2005

Nepafenac Metabolite, Amfenac, Inhibits VEGF Induced Phosphorylation of ERK in Human Retinal Microvascular Endothelial Cells

Q. Song; G.W. McCollum; R. Macrorie–Fairweather; D.P. Bingaman; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4204. doi:

ARVO Annual Meeting Abstract May 2004

VEGF Induction by Hypoxia in Muller cells

X. Qi; V.P. Sarthy; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1887. doi:

ARVO Annual Meeting Abstract May 2004

The Influence of Penetrating Ocular Injury on the Spatial and Temporal Distribution of PEDF mRNA and Protein in the Oxygen Injured Rat Retina

J.M. Barnett; J.D. Kay; V.S. Rajaratnam; K.A. Koepke; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1888. doi:

ARVO Annual Meeting Abstract May 2004

The Angiostatic Effect of Inositol

J.D. Kay; C.G. Gray; E. Tatum; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1913. doi:

ARVO Annual Meeting Abstract May 2004

Inhibition Of VEGF–Induced Endothelial Cell Poliferation And Differentiation By Steroidal And Non–steroidal Cox Inhibitors With Variable Cox–1/Cox–2 Selectivity

R. Yang; G.W. McCollum; D.P. Bingaman; J.S. Penn

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1914. doi:

ARVO Annual Meeting Abstract May 2003

A Soluble Ephrin Receptor Blocks Angiogenic Responses in Retinal Endothelial Cells and Inhibits Neovascularization in a Rat ROP Model

J.S. Penn; D. Hicks; G.W. McCollum; V.S. Rajaratnam; X. Qi; J. Chen

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):2882. doi:

ARVO Annual Meeting Abstract May 2003

Peroxisome Proliferator Activator Receptor (PPARs) Alpha, Beta and Gamma Expression and Effect of PPAR Ligand Treatment on Retinal Endothelial Cells, In Vitro

V.S. Rajaratnam; J.S. Penn; F.R. Haselton

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):2892. doi:

Advertisement